Asthma and Respiratory Disorders News

SAN DIEGO — A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.

Among children born in France, 83.1% had been prescribed a respiratory medication during the ages of 0 through 10 years, according to results published in Respiratory Medicine.

SAN DIEGO — Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, as well as with discontinuations, according to a series of posters presented here.

SAN DIEGO — Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used benralizumab, according to a poster presented here.

SAN DIEGO — Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically significant exacerbations, according to a poster abstract presented here.

SAN DIEGO — More research is needed to determine drivers of inhaler costs and patient knowledge on available financial assistance, according to a poster presentation here.

The FDA approved Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of multiple conditions including asthma and food allergy, according to an agency press release.

SAN DIEGO — Among inner-city children with asthma, daily inhaler adherence was “overestimated” by parents when compared with adherence captured via an electronic monitoring device, according to a presentation here.

SAN DIEGO — Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.